Neuronavigation rTMS to Improve Depressive Episodes of Bipolar Disorder in Adolescent - Trial NCT05929183
Access comprehensive clinical trial information for NCT05929183 through Pure Global AI's free database. This phase not specified trial is sponsored by First Affiliated Hospital of Zhejiang University and is currently Recruiting. The study focuses on Bipolar Disorder. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
First Affiliated Hospital of Zhejiang University
Timeline & Enrollment
N/A
Sep 01, 2022
Jul 30, 2023
Primary Outcome
Montgomery-Asberg Depression Rating Scale๏ผMADRS๏ผ
Summary
The purpose of this study is to explore a new stimulation target and protocol for the
 treatment of depressive episode in adolescents with bipolar disorder through the repetitive
 transcranial magnetic stimulation(rTMS) under neuronavigation, and verify whether there is
 abnormal functional connectivity between the emotion-related brain area orbital frontal lobe
 (OFC) and the primary visual cortex(V1) during the depressive episode, which will contribute
 to further understand the relevant neural pathway and mechanism.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05929183
Device Trial